- LinkedIn: https://www.linkedin.com/in/drew-endy-69ba17/
Professor Endy serves as Associate Chair of Education in Bioengineering. His research teams pioneered amplifying genetic logic, rewritable DNA data storage, reliably-reuseable standard biological parts, and genome refactoring. Drew helped launch the new undergraduate majors in bioengineering at both MIT and Stanford; he also co-founded the iGEM competition, a global genetic engineering “olympics” now engaging thousands of students annually (igem.org). In 2013 the White House recognized Drew for his work on open-source biotechnology and, more recently, he received an honorary doctorate from the Technische Universiteit Delft. Drew has served on the US National Science Advisory Board for Biosecurity and the standing committee on Science, Technology, & Law; he currently serves on the World Health Organization’s Smallpox Advisory Committee. Drew was a co-founder of Gen9, Inc., a DNA construction company; he returned to serve as a director while Gen9 was successfully acquired.
Drew worked briefly with the Rapid Evaluation team at Google [X] and also served on the project team for the Shriram Center at Stanford. He is a founding co-director of the NIST/Stanford Joint Initiative for Metrology in Biology (jimb.stanford.edu). Esquire magazine recognized Drew as one of the 75 most influential people of the 21st century.